BioMarin Pharmaceutical
BMRN
#1744
Rank
HK$93.32 B
Marketcap
HK$481.80
Share price
-0.02%
Change (1 day)
17.73%
Change (1 year)

P/S ratio for BioMarin Pharmaceutical (BMRN)

P/S ratio as of November 2026 (TTM): 3.25

According to BioMarin Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.88. At the end of 2026 the company had a P/S ratio of 3.03.

P/S ratio history for BioMarin Pharmaceutical from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20263.03-14.59%
20253.55-20.63%
20244.47-40.5%
20237.51-18.18%
20229.184.45%
20218.792.68%
20208.56-4.11%
20198.92-12.33%
201810.2-14.62%
201711.9-6.55%
201612.8-32.91%
201519.05.92%
201418.0-2.43%
201318.448.85%
201212.438.95%
20118.9012.36%
20107.9235.37%
20095.85-2.4%
20085.99-78.8%
200728.358.38%
200617.9-42.79%
200531.241.13%
200422.1-16.81%
200326.6-2.43%
200227.2-60.02%
200168.1

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Sanofi
SNY
1.89-42.06%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
2.40-26.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
0.8872-72.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
1.96-39.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
7.17 120.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
6.46 98.40%๐Ÿ‡บ๐Ÿ‡ธ USA